FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.

Polnaszek N, Kwabi-Addo B, Wang J, Ittmann M. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Prostate. 2004 Jun 15; 60(1):18-24.

View in: PubMed

authors with profiles

Bernard Kwabi-Addo

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support